Qube Research & Technologies LTD Axsome Therapeutics, Inc. Transaction History
Qube Research & Technologies LTD
- $65.7 Billion
- Q3 2024
A detailed history of Qube Research & Technologies LTD transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Qube Research & Technologies LTD holds 30,370 shares of AXSM stock, worth $4 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
30,370Holding current value
$4 Million% of portfolio
0.0%Shares
4 transactions
Others Institutions Holding AXSM
# of Institutions
335Shares Held
38.3MCall Options Held
899KPut Options Held
830K-
Rtw Investments, LP New York, NY4.19MShares$551 Million6.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.9MShares$513 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.3MShares$434 Million0.01% of portfolio
-
Fairmount Funds Management LLC Philadelphia, PA2.36MShares$310 Million34.46% of portfolio
-
Bvf Inc San Francisco, CA1.05MShares$138 Million2.99% of portfolio
About Axsome Therapeutics, Inc.
- Ticker AXSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,878,000
- Market Cap $5.64B
- Description
- Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...